Intellectual Property India Publishes Patent Application for 'Tricyclic Triazolo Compounds As Dgk Inhibitors' Filed by Incyte Corporation

MUMBAI, India, March 7 -- Intellectual Property India has published a patent application (202417104940 A) filed by Incyte Corporation, Wilmington, U.S.A., on Dec. 31, 2024, for 'tricyclic triazolo compounds as dgk inhibitors.'

Inventor(s) include Hummel, Joshua; Hie, Liana; Lacharity, Jacob J.; Li, Xiaolei; Manns, Sharada; Qian, Ding-Quan; Wang, Xiaozhao; Wei, Bo; and Xu, Meizhong.

The application for the patent was published on March 7, under issue no. 10/2025.

According to the abstract released by the Intellectual Property India: "The present application provides tricyclic triazolo compounds I that modulate the activity of diacylglycerol kinase (DGK), which are useful in the treatment of various diseases, including cancer."

The patent...